Article
Clinical genome sequencing in neurodegenerative diseases-outcome in the first 500 patients.
Human molecular genetics - 28 Jul 2026
Ehn Emma, Thonberg Håkan, Nennesmo Inger, Lindstrand Anna, Kvarnung Malin, Graff Caroline
Abstract excerpt
Neurodegenerative diseases (NDDs) are clinically and genetically heterogeneous, requiring neuropathology or molecular testing for a definitive diagnosis. Clinical whole genome sequencing (WGS) enables comprehensive variant calling across flexible gene lists that can be tailored to the clinical presentation. By allowing simultaneous detection of single-nucleotide variants, copy-number variants, structural...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
